Citrini Bets on Life Sciences After Testing Claude AI Drug Study
Citrini Research, after testing Anthropic's Claude Science, argues that AI-driven drug discovery will accelerate, benefiting life sciences companies. The firm is bullish on the sector's investment opportunities.